BLU
Closed
Bellus Health Inc.
14.74
0.00 (0.00%)
Last Update: 06 Jul 2023 16:30:00
Yesterday: 14.74
Day's Range: 14.74 - 14.74
Send
sign up or login to leave a comment!
When Written:
7.2
BELLUS Health Inc. is a biopharmaceutical company based in Laval, Quebec, Canada. The company is focused on the development and commercialization of novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders. Its lead drug candidate, BLU-5937, is a highly selective P2X3 antagonist that has shown promising results in Phase 2 clinical trials for the treatment of chronic cough. BELLUS Health was founded in 1993 and is publicly traded on the Toronto Stock Exchange (TSX: BLU).
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








